BOOK REVIEWS
we are told about the successes (or likely successes) of immunotherapy in most forms of cancer. Professor Mathe, this time with 19 co-authors, tells us again of the value of immunotherapy in ALL, and James Holland does the same in AML more cautiously. Others provide enthusiastic reports about most other forms of cancer. Unfortunately the only chapter which describes objective evidence of benefit from a properly controlled trial is that by Martin McKneally whose lung cancer trial remains about the only success which is not controversial (yet).
Pursuing its logical structure, the book ends with 3 chapters about the prospects for immunotherapy. They are optimistic, speculative and have a familiar ring about them: each could have been written 10 years ago. Michael Mastrangelo and his colleagues are the most rational, since they at least recognise that immunotherapy is "relatively ineffectual". These 3 chapters are depressing, since in reviewing the prospects for this form of treatment they exhibit a remarkable lack of new ideas, reflecting perhaps a remarkable lack of old ones.
The book ends not with a bang, but a whimper. The final chapter by Dr Jordan Gutterman is, as he says, a "call to arms". His view of the prospects for immunotherapy contains little science and is an attempt to bolster enthusiasm for the topic. His excitable brand of rhetoric would sound well on the hustings or in a pulpit, but in a scientific context has a hollow ring. He outlines and promotes an approach to clinical science which can only be described (complete with split infinitive) as the Startrek principle: "to boldly go where no man has gone before". To support his theme, that we should regard immunotherapy as a "good thing", he invokes Benjamin Disraeli, Arthur C. Clarke, Thomas Edison, Lord Rutherford, Jacob Bronowski, Mendel, Darwin, Einstein, the British Navy, God, Lewis Thomas (well, wrhy not?), Paul Ehrlich, Fleming, Florey and Chain, Gunther Grass, Robert Kennedy and an anonymous Rabbi. These illustrious names are however so much wallpaper. In the words of W. S. Gilbert, if I may indulge in the same namedropping ploy, they are "merely corroborative detail, intended to give artistic verisimilitude to an otherwise bold and unconvincing narrative". There is a useful section on the economic implications of tobacco, which spells out the costs of smoking, discusses the role of taxation, and indicates the harm to a country's economy that can stem from growing and processing tobacco, due to the requirement for a very large work-force in the peak harvest periods, the discouragement of other crops, the vast requirement for wood for curing, which is helping to spread deserts, the limited proportion of the crop that is exported in most countries, and the small part played in the balance of payments.
A chapter discusses smoking control, identifying the objectives, the role of government, and strategies at international and national levels and in relation to key groups, political and religious leaders, the health professions and teachers.
A chapter on public information and education programmes sets out in very general terms how these may be conducted; though the need for evaluation is stressed, the chapter did not document successful approaches.
More detail is provided in the next two chapters, which cover the control of smoking by legislation and restrictive measures, and various measures to help individuals to stop smoking. It is stated that the evidence from countries who have implemented comprehensive smoking control programmes has 'been encouraging'; some of the difficulties of helping individuals is discussed, and a warning given about the past tendency for some to report exaggerated claims for their methods of control.
The report ends with a strongly worded set of recommendations addressed to all countries. In this country there has already been a hint that the policy towards this health hazard may be tightened (Lancet, 1979 (Lancet, i, 1415 .
